Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia

被引：0
|
作者：
Aschalew Tamiru
Bethlehem Tigabu
Sisay Yifru
Ermias Diro
Asrat Hailu
机构：
[1] University of Gondar,Leishmaniasis Research and Treatment Center
[2] College of Medicine and Health Science,Tuberculosis Clinic
[3] University of Gondar,Department of Pediatrics
[4] College of Medicine and Health Science,Department of Internal Medicine
[5] University of Gondar,Department of Microbiology, Immunology and Parasitology, College of Health Sciences
[6] College of Medicine and Health Science,undefined
[7] University of Gondar,undefined
[8] College of Medicine and Health Science,undefined
[9] Addis Ababa University,undefined
来源：
BMC Infectious Diseases | / 16卷
关键词：
Liposomal amphotericin B; Visceral leishmaniasis; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients
    Rodríguez-Wilhelmi, P
    Panizo, C
    Ruza, E
    Rocha, E
    [J]. MEDICINA CLINICA, 2001, 116 (01): : 37 - 38
  • [12] Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Collazos, Julio
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 466 - 467
  • [13] Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries
    Berman, JD
    Badaro, R
    Thakur, CP
    Wasunna, KM
    Behbehani, K
    Davidson, R
    Kuzoe, F
    Pang, L
    Weerasuriya, K
    Bryceson, ADM
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1998, 76 (01) : 25 - 32
  • [14] Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia
    Diro, Ermias
    Lynen, Lutgarde
    Gebregziabiher, Berhane
    Assefa, Abraham
    Lakew, Wubishet
    Belew, Zewdu
    Hailu, Asrat
    Boelaert, Marleen
    van Griensven, Johan
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (01) : 8 - 16
  • [15] VISCERAL LEISHMANIASIS FOLLOWING TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B
    MCBRIDE, M
    LINNEY, M
    CLAYDON, EJ
    WEBER, J
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (02) : 362 - 362
  • [16] Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009
    Rosenthal, E.
    Delaunay, P.
    Jeandel, P. -Y.
    Haas, H.
    Pomares-Estran, C.
    Marty, P.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (10): : 741 - 744
  • [17] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT AND SECONDARY PROPHYLAXIS OF VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS - REPORT OF 2 CASES
    DUPLA, ML
    AGUADO, AG
    URIOL, PL
    GARCIA, VP
    ORTEGA, EV
    MARTINEZ, PM
    GARCIAPUIG, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) : 657 - 659
  • [18] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS IN PATIENTS COINFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    TORRECISNEROS, J
    VILLANUEVA, JL
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 191 - 191
  • [19] Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients-authors' response
    Molina, I.
    Falco, V.
    Crespo, M.
    Riera, C.
    Ribera, E.
    Curran, A.
    Carrio, J.
    Diaz, M.
    del Saz, S. Villar
    Fisa, R.
    Lopez-Chejade, P.
    Ocana, I.
    Pahissa, A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 467 - 467
  • [20] SUCCESSFUL TREATMENT OF RESISTANT VISCERAL LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B
    GOKHALE, PC
    KSHIRSAGAR, NA
    KHAN, MU
    PANDYA, SK
    MEISHERI, YV
    THAKUR, CP
    CHOUDHARY, CB
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (02) : 228 - 228
12345